To address one of the most important issues in the health system
Synapse Medicine is the intersection between medical pharmacology and research on artificial intelligence.
Its three founders are: Dr. Clément Goehrs, physician and bioinformatician; Dr. Louis Létinier, physician and pharmacologist; and Bruno Thiao-Layel, research engineer.
In the United States alone:
750older adults (aged 65 and older) are hospitalized every day due to serious adverse effects from one or more medications.
40%of people over 65 take more than 5 medications a day
(and 20% of people over 45).
$3.8 billionof costs, caused by more than 280 000 hospitalizations of older people in the U.S. in 2018 because of an adverse drug event
Rising from this context, Synapse Medicine has garnered support from the French National Institute of
Health and Medical Research (INSERM) and Bordeaux University Teaching Hospital. The product of 2
years of R&D is an artificial intelligence application dedicated to ensuring proper drug utilization.
Intuitive and and easy to use, this virtual assistant for drug information aims to guide healthcare professionals in their daily professional activities without disrupting practices.
Based in Bordeaux and California, Synapse Medicine is supported by a team of experts in the fields of medicine and artificial intelligence, including doctors and data scientists, who work closely with leading partners.
Creation of Synapse Medicine
Partnership with the prestigious Stanford University (USA).
Presentation of Synapse Medicine at CES, Las Vegas.
Test phase in collaboration with prescribing healthcare professionals.
Participated in Microsoft Experiences 18, the digital intelligence event.
First start-up specialized in AI to collaborate with Bordeaux University Teaching Hospital.
Clinical trial conducted at the emergency department of the University of Bordeaux teaching hospital on
the relevance of Synapse’s drug interactions tool.
Large-scale Synapse testing with a group of health insurance companies on tens of thousands of patients.
And some great successes to come:
Beginning of clinical studies in geriatric departments of the University of Bordeaux teaching hospital
Deploying Synapse application dedicated to individuals